Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy. Histiocyte Society

Clicks: 425
ID: 113043
1999
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
The familial form of hemophagocytic lymphohistiocytosis (HLH) is a lethal disorder. Although the prognosis for Epstein-Barr virus-associated HLH (EBV-HLH) remains uncertain, numerous reports indicate that it can also be fatal in a substantial proportion of cases. We therefore assessed the potential …
Reference Key
s1999bloodeffective Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Imashuku S;Hibi S;Ohara T;Iwai A;Sako M;Kato M;Arakawa H;Sotomatsu M;Kataoka S;Asami K;Hasegawa D;Kosaka Y;Sano K;Igarashi N;Maruhashi K;Ichimi R;Kawasaki H;Maeda N;Tanizawa A;Arai K;Abe T;Hisakawa H;Miyashita H;Henter JI;;
Journal Blood
Year 1999
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/10068659
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't female male Child Infant Remission Induction preschool DNA herpesvirus 4 Viral / analysis immunoglobulins intravenous / therapeutic use* histiocytosis immunosuppressive agents / therapeutic use pmid:10068659 s imashuku s hibi j i henter cyclosporine / therapeutic use dexamethasone / therapeutic use epstein-barr virus infections* etoposide / therapeutic use* glucocorticoids / therapeutic use human / genetics non-langerhans-cell / therapy* non-langerhans-cell / virology* prednisolone / therapeutic use steroids / therapeutic use*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.